Flor Veigas

PhD Student, Biotechnologist. Cancer research, immunology and transcriptomics 🧬

[Flor Veigas @florveigas]

👩‍🔬🙌
https://t.co/g1ShgoIw7j

[Arndt Vogel @ArndtVogel]

Tumor-Agnostic Precision Medicine from the AACR
GENIE Database: Clinical Implications
@CCR_AACR
https://t.co/OPrwZzekv4
👉Distribution of 5 tissue-agnostic targets with FDA approval among different cancer types : BRAFV600E, RET & NTRK fusions, TMBhigh & MSI
@myESMO

[The Struggling Scientists @TheStrugglingS4]

"I think we are close to submitting"

[The Struggling Scientists @TheStrugglingS4]

RUUUNN!!!

[The Struggling Scientists @TheStrugglingS4]

Just hand me that deck of cards 😂

[The Struggling Scientists @TheStrugglingS4]

Believe it or not this is what "well" looks like 🙈

[Omid Hamid MD @OmidHamidMD]

congrats @PAscierto a landmark paper illuminating the way for BRAF therapy in #melanoma #immunotherapy @NatureComms A must read !!!
https://t.co/9uTTrhSQir

[Nature Rev Immunol @NatRevImmunol]

Immunotherapy combination approaches: mechanisms, biomarkers and clinical observations https://t.co/RxnRHPenWY

[Daniela Robles @daniela-oaks.bsky.social @daniela_oaks]

Yesterday after we closed the @eventsWCS #CanGenAnalysis23 we had a team dance competition...

[Daniela Robles @daniela-oaks.bsky.social @daniela_oaks]

We close @eventsWCS #CanGenAnalysis23 with presentations by participants! All teams had to analyse TCGA data from different #cancer types and present its drivers, oncoplots, mutational signatures and clinical correlations. I think it was a success! 😀😀

[Malena Guinzburg @mguinzburg]

Por momentos vergüenza ajena. Pero la mayor parte del tiempo una angustia fuerte!

[Flor Veigas @florveigas]

La politica cada día me da más asco.

[Yanina Latorre @yanilatorre]

Un tipo q triplico el dolar. Y con un 140 de inflacion es candidato a presidente y encima apura al otro candidato. DE NO CREER

[Yanina Latorre @yanilatorre]

Q pesado Massa. Le esta haciendo un reportaje. NI UNA PROPUESTA. El ministro de economia q nos termino de fundir

[PHD Comics @PHDcomics]

Writing

[Immunity @ImmunityCP]

Online now: Targeting innate immune pathways for cancer immunotherapy https://t.co/cURlvXKrm7

[Benjamin Besse @BenjaminBesseMD]

Accumulative publications showing that immunotherapy is more potent when given early in the day. Time to change our practice and give our IOs in the morning? At least until evidence of a circadian biology supporting the hypothesis & availability of data from phase III trials?

[Flor Veigas @florveigas]

@HMAbushukair @AACR @ChaiWaiYeeng @PblSanchis @madewunmi23 Congrats!!

[Arndt Vogel @ArndtVogel]

Pembrolizumab in Patients With Tumors With High Tumor Mutational Burden: Results From the TAPUR Study
@JCO_ASCO
https://t.co/BUdhRmTwV9
👉efficacy, but only moderate association btw TMB and ORR, PFS, & OS
👉TMB alone is insufficient to predict benefit from ICIs
@myESMO @OncoAlert

[Norbert Kraut @norbertkraut1]

Pan-KRAS probe compounds BI-2865 and BI-2493 active against a broad range of oncogenic #KRAS variants that selectively inactivate downstream signaling and tumor growth, while sparing NRAS and HRAS. Now in print @nature #openaccess #precisiononcology
https://t.co/40IZvE0O5E